Levetiracetam Ever Pharma

Levetiracetam, the active ingredient in Levetiracetam Ever Pharma, is an antiepileptic presented as an intravenous solution for intravenous administration. It is used to manage partial‑onset seizures, primary generalized tonic‑clonic seizures, and other seizure types in patients diagnosed with epilepsy, providing a therapeutic option for both adult and pediatric populations.

GNH USA supplies Levetiracetam Ever Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics, and research institutions worldwide, ensuring quality‑assured product availability across diverse healthcare settings.

Levetiracetam is an antiepileptic medication used to control seizure activity in various forms of epilepsy.

- Partial seizures: reduces the frequency and severity of focal onset seizures. - Generalized seizures: helps control primary generalized tonic‑clonic seizures. - Epilepsy: provides overall seizure management for patients with a diagnosis of epilepsy.

Levetiracetam may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: generalized tiredness or lack of energy. - Somnolence: increased sleepiness during the day. - Headache: mild to moderate cranial pain. - Irritability: mood changes or agitation. - Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: rare but serious skin eruption. - Blood dyscrasias: neutropenia or thrombocytopenia. - Suicidal thoughts: emergence of depressive or suicidal ideation. - Severe skin rash: widespread erythema or blistering. - Respiratory depression: marked reduction in breathing effort.

When prescribing or handling Levetiracetam Ever Pharma, consider the following safety measures.

- Renal function: assess and monitor patients with impaired renal clearance. - Pregnancy: use only when the potential benefit justifies the potential risk to the fetus. - Breastfeeding: evaluate the risk‑benefit ratio before administration to nursing mothers. - Concomitant CNS depressants: monitor for additive sedation or respiratory effects. - Hematologic disorders: observe for changes in blood counts during therapy. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levetiracetam may interact with other medicines; awareness of the interaction level helps guide clinical decisions.

Major Interactions (Avoid): - Phenobarbital: may decrease levetiracetam plasma concentrations. - Phenytoin: may reduce levetiracetam exposure, potentially compromising seizure control. - Carbamazepine: can lower levetiracetam levels, requiring close monitoring.

Moderate Interactions (Monitor Closely): - NSAIDs: may affect renal clearance of levetiracetam in patients with renal impairment. - Antidepressants (e.g., SSRIs): may increase somnolence when combined. - Carbapenem antibiotics: may reduce levetiracetam efficacy, necessitating dose adjustment.